SEIHWAN Inc. is an artificial intelligence (AI) drug discovery company that magically innovates and accelerates the drug discovery journey.
From tractable(easy-to-develop) target identification to hit generation, our integrated AI and CADD platform generates unparalleled insights at every step to develop commercially valuable drugs in in-house and partnership projects.
Founded in 2022, the company is building an early-stage drug discovery integrated AI and CADD that will produce top-level lead compounds within six months.
SEIHWAN Inc. uses TGET and HGET to achieve automation of their molecular design workflows in their pursuit of full-stack AI-based industrial drug discovery, and the automation effort has been extended to the entire drug discovery process powered by the THOR platform. Includes THOR TGET for easy-to-develop target discovery, THOR HGET for hit discovery, THOR OGET (AI based Optimization & Patent Avoidance) for lead optimization, and THOR RGET for drug reuse.
THOR Platform : Tget(targets), Hget(Hits), Oget(Optimize), Rget(Reuse)
Contact to : ceo@seihwan.com